Metsera considers that the new offer from Novo Nordisk is superior to that of Pfizer
The logos of Danish pharmaceutical company Novo Nordisk, maker of the successful diabetes and weight loss treatments Ozempic and Wegovy,…
health care industry
Omada Health will begin prescribing GLP-1 and other obesity medications
The Omada Health logo is displayed on the screen of a smartphone. soup images | Light rocket | fake images…
Trump reaches agreement with Eli Lilly and Novo Nordisk
Wegovy injection pens laid out in Waterbury, Vermont, USA, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | fake…
Trump Republicans' Health Insurance
US President Donald Trump gestures as he speaks during an event to announce a deal with Eli Lilly and Novo…
Trump negotiates with Lilly and Novo Nordisk could expand access to anti-obesity drugs
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on November…
Trump, Eli Lilly and Novo Nordisk reveal agreements to reduce prices of anti-obesity drugs
US President Donald Trump attends an announcement event from the Oval Office of the White House in Washington, DC, United…
Eli Lilly's Obesity Drug Amylin Shows Up to 20% Weight Loss in Study
The Eli Lilly Biotechnology Center is shown in San Diego, California, on March 1, 2023. Mike Blake | Reuters Eli…
Pfizer and Novo Nordisk intensify Metsera bidding war
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Pfizer (PFE) earnings in the third quarter of 2025
Albert Bourla, CEO of Pfizer, speaks during a press conference after a visit to oversee the production of the Pfizer-BioNtech…
Pfizer files second lawsuit against Novo Nordisk and Metsera
A Pfizer logo is displayed at a research center in the La Jolla neighborhood of San Diego, California, U.S., on…